Kiniciti is focused on investing in opportunities with the potential to leverage technology and capabilities that can help drive transformational change and ensure the promise of cell and gene therapies is delivered to patients by assembling a science-driven platform that enables cell and gene therapeutic companies to advance therapies from early stage to commercial scale, addressing both speed to market and cost of goods – which will translate into more patients having access to these breakthrough treatments.

Contact Kiniciti
Visit Website